Filter Specialty
Submit To The Journals

Continuous Glucose Monitoring Adoption in the United Kingdom – An Economic and Policy Perspective

Authors: Nick Oliver
European Endocrinology, 2017;13(2):73–75 DOI:


Continuous glucose monitoring (CGM) technology provides real-time glucose concentration data to people with diabetes. The data enable timely treatment decisions that can lead to avoidance or mitigation of hypoglycaemia, with potential cost savings. This commentary discusses CGM implementation and funding policies in the UK, and regional disparities that confront many people with diabetes who could benefit from the technology.


Continuous glucose monitoring, commissioning, hypoglycaemia


Nick Oliver has received research support from Dexcom, Inc. This article is a short opinion piece and has not been submitted to external peer reviewers, but was reviewed by the editorial board for accuracy before publication.

Open Access

Open Access: This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation and reproduction provided the original.


July 03, 2017

Published Online

August 22, 2017


Nick Oliver, Section of Diabetes, Endocrinology and Metabolism, Faculty of Medicine, Imperial College, Du Cane Road, London, W12 0HS, UK. E:


The publication of this article was supported by Dexcom, Inc. The views and opinions expressed are those of the author and do not necessarily reflect those of Dexcom, Inc.

  • Touch Medical Media Limited, trading as Touch Medical Media, is a private limited company registered in England and Wales at The White House, Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142. © 2019 All rights reserved.

    touchendocrinology is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.